Eli Lilly's Retatrutide: A New Hope for Obesity and Sleep Apnea
Published on: June 7, 2026, midnight | Source: Devdiscourse
Eli Lilly's latest trial results show that its advanced obesity medication, Retatrutide, not only aids in weight reduction but also decreases the severity of sleep apnea. Additionally, the drug potentially alleviates knee pain, offering a multi-faceted solution to common health issues.
